COMPAZINE Drug Patent Profile
✉ Email this page to a colleague
When do Compazine patents expire, and what generic alternatives are available?
Compazine is a drug marketed by Glaxosmithkline and is included in seven NDAs.
The generic ingredient in COMPAZINE is prochlorperazine. There are twenty-one drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the prochlorperazine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Compazine
A generic version of COMPAZINE was approved as prochlorperazine by COSETTE on November 24th, 1993.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for COMPAZINE?
- What are the global sales for COMPAZINE?
- What is Average Wholesale Price for COMPAZINE?
Summary for COMPAZINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 7 |
| Raw Ingredient (Bulk) Api Vendors: | 57 |
| Clinical Trials: | 21 |
| DailyMed Link: | COMPAZINE at DailyMed |
Recent Clinical Trials for COMPAZINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Washington University School of Medicine | Phase 2 |
| Assertio Holdings, Inc | Phase 2 |
| Dayton Children's Hospital | N/A |
US Patents and Regulatory Information for COMPAZINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaxosmithkline | COMPAZINE | prochlorperazine maleate | CAPSULE, EXTENDED RELEASE;ORAL | 011000-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glaxosmithkline | COMPAZINE | prochlorperazine edisylate | CONCENTRATE;ORAL | 011276-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glaxosmithkline | COMPAZINE | prochlorperazine maleate | CAPSULE, EXTENDED RELEASE;ORAL | 021019-002 | Oct 6, 1999 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glaxosmithkline | COMPAZINE | prochlorperazine edisylate | SYRUP;ORAL | 011188-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glaxosmithkline | COMPAZINE | prochlorperazine edisylate | INJECTABLE;INJECTION | 010742-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
